UTI - Healthcare Fund
UTI Mutual Fund · Sectoral/Thematic · Direct plan, growth option
| Period | Scheme | Category median | Healthcare & pharma median |
|---|---|---|---|
| 1 month | -3.2% | -5.4% | -3.1% |
| 3 months | 2.3% | -2.8% | 3.0% |
| 6 months | 22.6% | 8.9% | 21.7% |
| Year to date | 17.7% | -2.0% | 17.3% |
| 1 year | 16.7% | 1.4% | 17.5% |
| 3 years (CAGR) | 22.5% | 13.0% | 20.8% |
| 5 years (CAGR) | 15.3% | 12.0% | 15.3% |
| 7 years (CAGR) | 24.5% | 17.0% | 24.9% |
| 10 years (CAGR) | 14.7% | 14.6% | 14.7% |
| Since first NAV (CAGR) | 16.3% | – | – |
“Healthcare & pharma” is MFIC's grouping of Sectoral/Thematic schemes by the theme or index in their names, not an AMFI category.
| Measure | Scheme | Category median |
|---|---|---|
| 1Y rolling median | 12.8% | 11.8% |
| 3Y rolling median | 17.9% | 17.5% |
| 3Y rolling worst | -6.5% | 3.0% |
| 3Y periods positive | 84% | 100% |
| 3Y periods ahead of benchmark | 68% | 84% |
| 5Y rolling median | 13.6% | 15.6% |
| 5Y rolling worst | -4.5% | 1.8% |
| 5Y periods ahead of benchmark | 74% | 91% |
Benchmark: Nifty 500 (proxy: Motilal Oswal Nifty 500 Index Fund, price return).
| Measure | Scheme | Category median |
|---|---|---|
| Standard deviation (ann.) | 15.9% | 16.7% |
| Sharpe ratio | 1.10 | 0.42 |
| Sortino ratio | 1.99 | 0.63 |
| Beta | 0.76 | 0.96 |
| Alpha (ann.) | 14.9% | 3.7% |
| Upside capture | 123.62 | 106.94 |
| Downside capture | 59.15 | 95.17 |
| Measure | Scheme | Category median |
|---|---|---|
| Maximum drawdown, full history | −27.1% | −23.1% |
| Maximum drawdown, last 10Y | −22.6% | −38.3% |
| Maximum drawdown, last 5Y | −21.1% | −22.3% |
| Current drawdown | −4.1% | −8.3% |
| Recovery time of worst fall | 35 days | – |
Longer histories include more crises, so compare the 5Y and 10Y figures across schemes of different ages.
| Measure | Scheme | Category median |
|---|---|---|
| Expense ratio (TER), Direct plan | 1.34% | 1.23% |
| AUM, whole scheme (₹ crore) | 1,430 | 1,272 |
| Riskometer | Very High | – |
TER: AMFI, TER of MF Schemes. AUM and riskometer: AMFI, Fund Performance, 30 Sep 2026.
| Measure | Scheme | Benchmark / category |
|---|---|---|
| Return, 1 year (AMFI) | 18.3% | 16.8% TRI |
| Return, 3 years (AMFI) | 22.6% | 21.3% TRI |
| Return, 5 years (AMFI) | 15.5% | 14.6% TRI |
| Month-ends above category median (3Y CAGR) | 50% | 53% median |
| Month-ends in category top quartile (3Y) | 39% | 24% median |
| 7Y rolling CAGR, median (monthly windows) | 14.0% | 15.2% median |
Official benchmark: BSE Healthcare TRI (total return index, as published by AMFI). Category consistency: last 10 years of month-ends, Sectoral/Thematic Direct plans; how it is calculated.
| Year | Scheme | Nifty 500 proxy | Difference |
|---|---|---|---|
| 2026 YTD | 17.7% | -7.8% | +25.5% |
| 2025 | -2.2% | 7.7% | −9.9% |
| 2024 | 44.3% | 15.6% | +28.6% |
| 2023 | 39.6% | 26.5% | +13.0% |
| 2022 | -11.3% | 3.8% | −15.1% |
| 2021 | 20.3% | 30.6% | −10.3% |
| 2020 | 68.9% | 17.2% | +51.7% |
| 2019 | 2.2% | n/a | – |
| 2018 | -6.5% | n/a | – |
| 2017 | 7.2% | n/a | – |
Benchmark proxy: Motilal Oswal Nifty 500 Index Fund (Direct plan NAV, price return), which carries its own costs. The first year starts from the first 31 December in the scheme's history.
| Period | Invested | Value | XIRR |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,34,758 | 23.6% |
| 3 years | ₹3,60,000 | ₹4,66,784 | 17.6% |
| 5 years | ₹6,00,000 | ₹10,02,686 | 20.6% |
| 10 years | ₹12,00,000 | ₹32,76,521 | 19.1% |
Uses this plan's NAVs; ignores stamp duty, exit loads and taxes. One historical path only — the interactive SIP analyzer shows outcomes across every start date.
| Scheme | Category | Correlation | 3Y CAGR |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund | Sectoral/Thematic | 0.98 | 30.2% |
| ICICI Prudential Healthcare Fund | Sectoral/Thematic | 0.97 | 21.1% |
| Mirae Asset Healthcare Fund | Sectoral/Thematic | 0.97 | 21.8% |
| ITI Pharma and Healthcare Fund | Sectoral/Thematic | 0.97 | 18.9% |
| Aditya Birla Sun Life Pharma and Healthcare Fund | Sectoral/Thematic | 0.97 | 20.1% |
| Tata India Pharma & Healthcare Fund | Sectoral/Thematic | 0.97 | 18.3% |
- What is the latest NAV of UTI - Healthcare Fund?
- The NAV of the Direct plan (growth option) was ₹378.6495 on 2 Oct 2026, as published by AMFI.
- Which category is UTI - Healthcare Fund in?
- It is classified as Sectoral/Thematic in AMFI's daily NAV file; a Sectoral/Thematic scheme invests at least 80% in one sector or theme. MFIC compares it with 253 Sectoral/Thematic schemes (Direct plans).
- What returns has UTI - Healthcare Fund delivered?
- Over one year the NAV changed by 16.7%. The 3-year CAGR is 22.5% (category median 13.0%) and the 5-year CAGR is 15.3% (category median 12.0%). Returns are after expenses and before tax. Past performance may or may not be sustained in future.
- How consistent have its 3-year returns been?
- Measuring a 3-year CAGR from every business day in its history, the median was 17.9%, the lowest was -6.5%, and 84% of 3-year periods ended with a gain. It was ahead of Nifty 500 (index-fund proxy) in 68% of those periods.
- What was the largest fall in UTI - Healthcare Fund's NAV?
- The largest peak-to-trough fall in its available history was 27.1%; within the last five years it was 21.1% (category median 22.3%).
- How volatile is UTI - Healthcare Fund?
- Its annualised standard deviation of monthly returns over the last 36 months is 15.9%, which is below the Sectoral/Thematic category median of 16.7%.
- What would a monthly SIP in UTI - Healthcare Fund have grown to?
- A SIP of ₹10,000 on the first business day of each month for the last 5 years (60 instalments, ₹6,00,000 invested) would have been worth about ₹10,02,686 on 2 Oct 2026, an annualised return (XIRR) of 20.6%. This uses the Direct plan's NAVs, ignores taxes and exit loads, and past performance may or may not be sustained in future.
- What is the expense ratio (TER) of UTI - Healthcare Fund?
- The total expense ratio of the Direct plan is 1.34% a year, as disclosed to AMFI (median of Sectoral/Thematic Direct plans: 1.23%). It is already deducted from the NAV, so every return shown is after expenses.
- How large is UTI - Healthcare Fund?
- Assets under management of the whole scheme were ₹1,430 crore on 30 Sep 2026, as published by AMFI.
- What is the riskometer level of UTI - Healthcare Fund?
- AMFI lists the scheme's riskometer as “Very High”, and its benchmark's as “Very High”. The riskometer is a label of potential risk set under SEBI rules, not a forecast.
- What is the benchmark of UTI - Healthcare Fund and how has it compared?
- Its official benchmark is the BSE Healthcare TRI. Over 3 years AMFI reports a return of 22.6% for this plan against 21.3% for the benchmark total return index; over 5 years 15.5% against 14.6%. Past performance does not indicate future results.
- How often has UTI - Healthcare Fund beaten its category?
- At 50% of the 120 month-ends compared over the last 10 years, its 3-year return was above the median of Sectoral/Thematic schemes (Direct plans); it was in the top quarter at 39% of them. A typical scheme would show about 50%.
- What is the difference between the Direct and Regular plans?
- Both plans hold the same portfolio; the Regular plan includes distribution costs in its expense ratio. Over one year the Direct plan's NAV changed by 16.7% and the Regular plan's by 15.5%. The Regular plan includes the services of a distributor.
Every Monday: this scheme's NAV, 1-month and 1-year return beside its category median, 3-year CAGR and how far it is below its peak. Add more schemes from their pages or from your MFIC watchlist. Free; unsubscribe from any email.